XCUR
Exicure, Inc. - Common Stock (XCUR)
$89
About Exicure, Inc. - Common Stock (XCUR)
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.
Details
Daily high
$0.93
Daily low
$0.86
Price at open
$0.89
52 Week High
$9.48
52 Week Low
$0.86
Market cap
5.8M
Dividend yield
-
Volume
15,317
Avg. volume
67,161
P/E ratio
-.68
Exicure, Inc. - Common Stock News
Details
Daily high
$0.93
Daily low
$0.86
Price at open
$0.89
52 Week High
$9.48
52 Week Low
$0.86
Market cap
5.8M
Dividend yield
-
Volume
15,317
Avg. volume
67,161
P/E ratio
-.68